Who owns ADC Therapeutics SA?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ADCT from SEC Form 13F filings across 110 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 110 institutions disclosed 82.0M shares of ADC Therapeutics SA worth $100.0M — about 52.7% of shares outstanding; the largest disclosed holder is Nantahala Capital Management, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
110
13F holders
$100.0M
value, 2026 filers
52.7%
of shares outstanding (82.0M sh)
18
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of ADCT's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Nantahala Capital Management, LLC | 12.6M | $15.3M | 0.5% | 8.1% | +2.0% |
| 2 | Redmile Group, LLC | 11.6M | $14.1M | 1.0% | 7.5% | +0.5% |
| 3 | TCG Crossover Management, LLC | 11.4M | $13.9M | 0.4% | 7.3% | 0.0% |
| 4 | BlackRock, Inc. | 7.2M | $8.8M | 0.0% | 4.6% | +2.3% |
| 5 | AIGH Capital Management LLCNEW | 4.3M | $5.3M | 0.5% | 2.8% | new |
| 6 | Opaleye Management Inc. | 4.1M | $5.0M | 0.6% | 2.6% | +481.5% |
| 7 | GOLDMAN SACHS GROUP INC | 3.5M | $4.3M | 0.0% | 2.2% | +82.1% |
| 8 | MORGAN STANLEY | 2.7M | $3.3M | 0.0% | 1.7% | -10.9% |
| 9 | CITADEL ADVISORS LLC | 2.4M | $3.0M | 0.0% | 1.6% | +19.2% |
| 10 | AQR CAPITAL MANAGEMENT LLC | 2.3M | $2.7M | 0.0% | 1.4% | +241.9% |
| 11 | STATE STREET CORP | 1.7M | $2.1M | 0.0% | 1.1% | +1.0% |
| 12 | TWO SIGMA INVESTMENTS, LP | 1.6M | $2.0M | 0.0% | 1% | +108.9% |
| 13 | D. E. Shaw & Co., Inc. | 1.5M | $1.8M | 0.0% | 1% | +110.5% |
| 14 | GEODE CAPITAL MANAGEMENT, LLC | 1.5M | $1.8M | 0.0% | 1% | +4.7% |
| 15 | BANK OF AMERICA CORP /DE/ | 1.3M | $1.6M | 0.0% | 0.8% | +0.1% |
| 16 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.1M | $1.3M | 0.0% | 0.7% | +20.6% |
| 17 | ACADIAN ASSET MANAGEMENT LLC | 1.0M | $1.2M | 0.0% | 0.6% | +179.4% |
| 18 | UBS Group AG | 773,698 | $943,912 | 0.0% | 0.5% | +48.7% |
| 19 | Blue Owl Capital Holdings LP | 733,568 | $894,953 | 0.2% | 0.5% | 0.0% |
| 20 | PANAGORA ASSET MANAGEMENT INC | 695,401 | $848,389 | 0.0% | 0.4% | +21.4% |
| 21 | JANE STREET GROUP, LLC | 641,221 | $782,290 | 0.0% | 0.4% | +946.6% |
| 22 | BNP PARIBAS FINANCIAL MARKETS | 632,568 | $771,733 | 0.0% | 0.4% | -3.1% |
| 23 | NORTHERN TRUST CORP | 593,895 | $724,552 | 0.0% | 0.4% | 0.0% |
| 24 | PLATINUM INVESTMENT MANAGEMENT LTD | 581,609 | $709,563 | 0.4% | 0.4% | 0.0% |
| 25 | Point72 Asset Management, L.P. | 447,786 | $546,299 | 0.0% | 0.3% | -87.7% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.